India — Central Drugs Laboratory
Tracked across 2 events · 22 articles · First seen Dec 27, 2025 · Last active Sep 05, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: The laboratory's testing identified the potency failure and discrepancies, triggering the regulatory action.
Sep 04, 2026 · 7 articles
Regulatory
Impact: The India — Central Drugs Laboratory, a Government of India entity, is responsible for testing and releasing every batch of vaccine manufactured in India, including Abhayrab, before it is made available for sale or administration.
Dec 27, 2025 · 15 articles
ERGEN INTELLIGENCE
Track India — Central Drugs Laboratory live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard